Green Shield Canada: Preferential Status Is Vital to Biosimilar Uptake
April 12th 2021
ArticleTo overcome provider and patient preferences for brand originators, there has to be more of an incentive to use biosimilars, explains Nedzad Pojskic, PhD, MSc, Green Shield Canada.